- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
In an exclusive podcast interview, Merck's Dr. Reid Leonard discusses the company's commitment to collaboration.
The leaders at Merck know that dynamic advances in R&D are often the result of synergistic partnership rather than individual effort, and their company has taken this position to heart. As one of the leading Corporate Symposium Sponsors for Nanotech 2008, the company hopes to use its visibility to attract the collaboration of promising talent in turning scientific breakthroughs into beneficial medicines and therapies.
"Our motivation for setting up this symposium is to create an opportunity for people to talk with us about what they're doing," said Dr. Reid Leonard, Executive Director of Licensing and External Research for Merck Laboratories. "We're really interested in talking with scientists from academia, biotech, technology platform companies - all of these groups are welcome to explore ways that Merck can work with them to advance the state of the art in this exciting new field of RNAi-based therapies."
The symposium, scheduled for Tuesday, June 3, from 3:30 - 6:30 p.m., will feature presentations covering a wide range of siRNA-related topics, and will be introduced by Dr. Alan Sachs, Merck's head of RNAi Therapeutics. A reception will follow the program.
"This is really an opportunity for researchers working on the topic of RNAi delivery to come together and share insights amongst themselves," said Dr. Leonard. "Our poster session, platform talk, and reception are designed to provide an opportunity for networking among all of these interested scientists."
"We really do have a rich heritage in RNA-based research," Dr. Leonard added, "and we hope that people will come to the event to learn what we're doing - and more importantly, what we can do together."
The Merck Innovation Symposium will take place on Tuesday, June 3, in room 208 of the Hynes Convention Center in Boston as part of NSTI Nanotech 2008.
The Nano Science and Technology Institute (NSTI) is chartered with the promotion and integration of nano and other advanced technologies through education, technology and business development. NSTI accomplishes this mission through its offerings of continuing education programs, scientific and business publishing and community outreach. NSTI produces the annual Nanotech conference and trade show, the most comprehensive international nanotechnology convention in the world. NSTI also produces the semi-annual Nanotech Venture, Nanotech Industrial Impact Workshop, Nano Impact Summit and the Nanotech Course Series in the US and Europe. NSTI was founded in 1997 as a result of the merger between various scientific societies, and is headquartered in Cambridge, Massachusetts with additional offices in California and Switzerland.
For more information, please click here
696 San Ramon Valley Blvd., Ste. 423
Danville, CA 94526
Ph: (925) 901-4959
Fax: (925) 886-8461
Copyright © NSTIIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Yale researchers’ technology turns wasted heat into power June 27th, 2016
Call for NanoArt and Art-Science-Technology Papers June 9th, 2016
Novel gene therapy shows potential for lung repair in asthma May 18th, 2016
FEI and University of Liverpool Announce QEMSCAN Research Initiative: University of Liverpool will utilize FEI’s QEMSCAN technology to gain a better insight into oil and gas reserves & potentially change the approach to evaluating them June 22nd, 2016
French Research Team Helps Extend MRI Detection of Diseases & Lower Health-Care Costs: CEA, INSERM and G2ELab Brings Grenoble Region’s Expertise In Advanced Medicine & Magnetism Applications to H2020 IDentIFY Project June 21st, 2016